29 Mar 2021 --- Swedish probiotic player Probi is partnering with China National Pharmaceutical Foreign Trade Corporation (Sinopharm), one of China’s largest pharmaceutical and healthcare companies, to launch three probiotic supplements within the immune health, bone health and iron absorption arenas. The products will be based on Probi’s scientifically proven probiotic strains. The move is tapping into the premium probiotic offerings segment in the Chinese market, which is rapidly gaining momentum, according to the company.
